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The membrane-bound form of 
acetylcholinesterase (AChE) constitutes the 
major component of this enzyme in the 
mammalian brain. These molecules are hetero-
oligomers, composed of four AChE catalytic 
subunits of type T (AChET), associated with a 
transmembrane protein of type 1, called 
PRiMA (Proline Rich Membrane Anchor). 
PRiMA consists of a signal peptide, an 
extracellular domain that contains a proline-
rich motif (14 prolines with an intervening 
leucine, P4LP10), a transmembrane domain 
and a cytoplasmic domain. Expression of 
AChET subunits in transfected COS cells with a 
truncated PRiMA, without its transmembrane 
and cytoplasmic domains (Pstp54 mutant), 
produced secreted heteromeric complexes (T4-
Pstp54), instead of membrane-bound tetramers. 
In this study, we used a series of deletions and 
point mutations to analyze the interaction 
between the extracellular domain of PRiMA 
and AChET subunits. We confirmed the 
importance of the poly-proline stretches and 
defined a peptidic motif (RP4LP10RL), which 
induces the assembly and secretion of a 
heteromeric complex with four AChET 
subunits, nearly as efficiently as the entire 
extracellular domain of PRiMA. It is 
noteworthy that deletion of the N-terminal 
segment preceding the prolines had little effect. 
Interestingly, short PRiMA mutants, truncated 
within the proline-rich motif, reduced both 
cellular and secreted AChE activity, suggesting 
that their interaction with AChET subunits  
induces their intracellular degradation.  
 
In the nervous tissue and muscles of 
mammals, acetylcholinesterase (AChE, EC 3.1.1.7) 
controls cholinergic transmission by rapidly 
hydrolyzing the neurotransmitter acetylcholine after 
its release from nerve terminals. The functional 
localization of AChE depends on the association of 
its T splice variant with structural proteins (1-4). 
Thus, the physiologically active AChE species 
correspond essentially to the collagen-tailed forms 
at the neuromuscular junctions and to membrane-
bound tetramers in the brain.  
The AChET splice variant is characterized 
by its 40-residues C-terminal peptide (t peptide), 
which contains a C-terminal cysteine and seven 
aromatic residues, including three evenly spaced 
tryptophans, and can be organized as an 
amphiphilic alpha helix (5). This peptide behaves 
as an autonomous interaction domain (the 
Tryptophan (W) Amphiphilic Tetramerization 
domain, or WAT) (6): it allows oligomerization of 
AChET subunits into homomeric dimers (T2) and 
tetramers (T4), as well as heteromeric associations 
of tetramers with anchoring proteins (7-9). 
In the collagen-tailed forms, AChET 
tetramers are associated with a specific collagen, 
called ColQ (7,10). This interaction has been 
extensively studied: it is based on a tight interaction 
between four t peptides (6) and a proline-rich motif, 
called PRAD  (″Proline-Rich Attachment 
Domain″), located in the N-terminal non 
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collagenous region of ColQ (11). Synthetic t and 
PRAD peptides (respectively 40 and 15 residues) 
spontaneously form a complex, the structure of 
which has been determined by crystallography: four 
alpha-helical t peptides form a staggered coiled-coil 
around the PRAD, organized as an elongated poly-
proline II helix (12). All aromatic residues are 
oriented towards the interior of this compact 
cylindrical complex, and the tryptophans are 
apposed to the rings of the proline residues. From 
this interaction, it was possible to deduce models 
for the quaternary organization of four AChET 
subunits linked to a ColQ chain (12,13). 
The existence of an N-glycosylated 20 
kDa hydrophobic protein, associated with 
membrane-bound AChE tetramers was originally 
discovered by Gennari and Brodbeck and by 
Inestrosa et al., in 1987 (14,15); this membrane 
anchor was more recently cloned and called 
PRiMA (“Proline-Rich Membrane Anchor”), 
because it contains a proline-rich motif, like ColQ 
(16). This suggests that AChET subunits may 
associate with PRiMA and with ColQ in a similar 
manner. However, there are significant differences 
in the numbers of prolines (8 in ColQ, 14 in 
PRiMA) and in the numbers and positions of 
cysteines that could form intercatenary disulfide 
bonds with a cysteine located near the C-terminus 
of each of the four t peptides. In addition, PRiMA 
contains a putative N-glycosylation site between 
the poly-proline stretches and the transmembrane 
domain (17). Alternative splicing produces two 
PRiMA variants, which differ in their C-terminal 
domains: the intracellular domains of the major 
variant (PRiMA I) and of the minor variant 
(PRiMA II) contain respectively 40 and 11 residues 
(18). The mode of association between PRiMA and 
AChET subunits is physiologically important since 
the resulting PRiMA-anchored AChE tetramers 
(16,18) represent the major enzyme species in the 
brain (18) and their level is regulated by exercise in 
muscles (19). 
We have undertaken an analysis of the 
association of AChET with PRiMA. In this study, 
we mostly used truncated PRiMA mutants 
containing only the extracellular domain or 
fragments of this domain, but not the 
transmembrane and cytoplasmic domains, thus 
producing soluble heteromeric complexes with 
AChET subunits. In previous studies, we have 
shown that a significant fraction of AChET subunits 
is degraded intracellularly, through the ERAD 
process (“Endoplasmic Reticulum Associated 
Degradation”) (20,21), and that this is mostly 
induced by exposed aromatic residues (21,22), in 
agreement with the fact that the formation of a 
complex in which these residues are occluded may 
reduce their degradation and increase their 
secretion. In the present study, we examine how co-
expression with PRiMA mutants affects the 
trafficking, degradation and secretion of AChET 
subunits. We show that some truncated mutants of 
PRiMA act as degradation inducers, assembling 
AChET subunits into complexes which are 
degraded intracellularly, indicating that they fail to 
pass the quality control of the secretory pathway. 
Using deletions and mutations, we analyze the 
influence of residues flanking the poly-proline 
stretches and also of the leucine located between 
the prolines, and we define a peptidic motif 
(RP4LP10RL), which is nearly as efficient as the 
complete extracellular domain of PRiMA for 
recruitment of AChET subunits into secreted 
heteromeric complexes. 
 
Experimental Procedures 
 
Vectors and site directed mutagenesis - The AChET 
subunit of rat AChE, as well as intact or mutated 
mouse PRiMA were expressed by inserting the 
corresponding cDNAs into pEF-Bos vectors (23). 
Throughout the present article, the numbering of 
PRiMA residues corresponds to the mature protein 
(Fig. 1A); the extracellular domain corresponds to 
residues 1-53. Mutagenesis was performed by the 
method of Kunkel et al. (24), as described 
previously (25). For deletions, we used mutagenic 
oligonucleotides of about 30 nt containing 15 nt on 
each site of the deleted fragment. Truncated 
mutants are indicated by the position of stop codons 
and by the modified residues: for example, R36E-
Pstp37 indicates a mutant in which a stop codon was 
introduced at position 37 and arginine R36 was 
replaced by a glutamic acid. Fig. 1B shows the 
structure of mutants used in this study. We 
introduced a flag epitope (DYKDE) after the 
cleavage site of the signal peptide in PRiMA, so 
that it was recognized by the anti-flag monoclonal 
antibody M1 (Sigma). We also used an N-terminal 
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fragment of Torpedo ColQ, with or without its 
PRAD domain (Fig. 1C). 
Transfection in COS cells - Plasmids were 
transfected in COS cells with the DEAE-dextran 
method, as described previously (9), using 2 µg of 
vector DNA encoding the catalytic subunit AChET 
and various amounts of vector DNA encoding 
PRiMA mutants, as specified, per 60 mm dish. For 
comparison, we also used an N-terminal fragment 
of Torpedo marmorata ColQ (Qstp69). In each 
series of transfections, we completed the amount of 
vector encoding PRiMA mutants with a vector 
encoding a non interacting protein, the N-terminal 
domain of ColQ from which the PRAD interaction 
motif was deleted (∆[28-44]-Qstp69) (11), so that 
the total amount of vector remained constant, to 
avoid changes in the synthetic capacity of the cells. 
After transfection, COS cells were incubated at 
37°C, in a medium containing 10% NUserum 
(Inotech, Dottikon, Switzerland), which had been 
pre-treated with 10-5 M soman to inactivate serum 
cholinesterases. The medium and the cells were 
collected after 3-4 days.  
 
Analysis of AChE recovery after irreversible 
inhibition - The AChE activity of transfected cells 
(3 or 4 days after transfection) was irreversibly 
inhibited by incubation with the membrane-
permeant inhibitor soman (pinacolylmethyl-
phosphonofluoridate) at 5 10-7 M for 30 min, as 
described in (22). After extensive washing, the 
recovery of AChE activity was determined by 
collecting cells at various times in fresh culture 
medium at 37 °C. Secretion of newly synthesized 
AChE only resumed after about 150-180 min and 
during that period the recovery of cellular activity 
reflected a balance between neosynthesis and 
intracellular degradation. 
 
Cell extracts - Intracellular and membrane-bound 
AChE was extracted for 15 min at 20°C in a TMg 
buffer (1% Triton X-100, 50 mM Tris-HCl, pH 7.5, 
10 mM MgCl2) containing 25 mM benzamidine, 
followed by centrifugation for 10 min at 13 000 
r.p.m at 4°C. The culture medium containing the 
secreted enzyme was also centrifuged at 13 000 
r.p.m for 10 min to remove cell debris before 
analysis. 
 
Enzyme assays - AChE activity was determined 
with the colorimetric method of Ellman et al. (26) 
at room temperature. The reaction was monitored at 
414 nm with a Labsystems Multiskan RC automatic 
plate reader (Helsinki, Finland); the optical density 
was recorded at 20 s intervals over a period of 10 
min. Alkaline phosphatase and β-galactosidase 
from Escherichia coli were assayed with the 
chromogenic substrates p-nitrophenyl phosphate 
and o-nitrophenyl galactoside, respectively. 
 
Sedimentation and electrophoresis analyses - 
Centrifugation in 5-20 % sucrose gradients (50 mM 
Tris-HCl pH 7.5, 20 mM MgCl2, in the presence of 
1 % Brij-96 or 0.2% Triton X-100) was performed 
in a Beckman SW41 rotor, at 36 000 r.p.m, for 17 h 
30 at 6°C. Approximately 40 fractions were 
collected and AChE activity was measured with the 
Ellman colorimetric assay, allowing the 
determination of the sedimentation coefficients of 
the different molecular forms, and of their relative 
activities. The gradients contained E. coli β-
galactosidase (16 S) and alkaline phosphatase (6.1 
S) as internal sedimentation standards. Amphiphilic 
molecules are characterized by the fact that they 
interact with detergent micelles: they generally 
sediment slower in the presence of Brij-96 than of 
Triton X-100.  
Electrophoresis in non-denaturing 
polyacrylamide gels was performed as described by 
Bon et al. (27); The gels contained 0.25% Triton X-
100 with or without 0.05% deoxycholate; 
electrophoresis was performed in a refrigerated 
apparatus under 40 V/cm, for 2 h. Enzymatic 
activity was revealed by the histochemical method 
of Karnovsky and Roots (28). This method allows a 
rapid qualitative comparison of up to 20 samples in 
a single gel. In charge shift electrophoresis, the 
electrophoretic migration of amphiphilic molecules 
was accelerated in the presence of sodium 
deoxycholate, when compared to migration in the 
presence of the neutral detergent, Triton X-100. 
 
Effect of synthetic peptides on oligomerization of 
AChET subunits - Synthetic peptides corresponding 
to the interaction motif of PRiMA, (RP4LP10 and 
RP4LP10RL) were synthesized by the Merrifield 
solid phase method in an Applied Biosystems 
(ABI) 431A automated peptide synthesizer, with 
small-scale 9-fluorenylmethoxycarbonyl (Fmoc) 
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chemistry (29). Protected amino acids were 
purchased from Applied Biosystems (Foster City, 
CA) (30). Crude peptides were purified by reverse-
phase HPLC on a Vydac C18 column (5 µm, 250 x 
10 mm2), using appropriate acetonitrile gradients 
containing 0.1% TFA.  
A 10-2 M solution of peptide in Tris-HCl 
pH 8 (1 M) was added with fresh medium to 
transfected COS cells expressing only AChET 
subunits, at a final concentration of 10-4 M. 
Peptides were also added to cell homogenates, at a 
final concentration of 10-4 M, and incubated 
overnight at 20°C or 37°C. In some samples, a 
synthetic t peptide (WAT) was added at 2 10-4 M. 
The oligomeric state of AChE was then analyzed 
by non-denaturing electrophoresis, after dilution 
two-fold in buffer containing 1% Triton X-100. 
 
RESULTS 
 
PRiMA mutants - Fig. 1A shows the primary 
sequence of mouse PRiMA, and the structure of 
mutants used in this study. PRiMA comprises a 
signal peptide (residues -35 to -1), an extracellular 
N-terminal domain (residues 1 to 53) that includes 
four cysteines, a proline-rich motif and a putative 
N-glycosylation site, a transmembrane domain 
(residues 54 to 78) and two possible cytoplasmic C-
terminal domains, that define PRiMA I and PRiMA 
II. We studied the interaction of AChET subunits 
with the extracellular domain of PRiMA, using 
mutants lacking the transmembrane and 
cytoplasmic domains (Fig. 1B). Firstly, we 
introduced stop codons at various positions (n), 
producing proteins Pstpn. Secondly, we deleted 
most of the N-terminal region preceding the 
prolines, in mutants designed as ∆N; to maintain a 
correct signal peptide cleavage site, we conserved 
the first or the last residue of this region (E1 and 
R20, respectively). We also assessed the possible 
influence of electrostatic effects, by mutating the 
residue preceding the prolines by other charged or 
uncharged residues (D, K or A). Finally, we 
analyzed the role of the leucine located within the 
poly-proline region (L25), by replacing it with a 
proline, and by adding a leucine at position 31, with 
or without the original leucine. Thus the original 
motif P4LP10 was changed to P15, P10LP4 and 
P4LP5LP4. 
 
Formation and secretion of soluble complexes with 
truncated PRiMA mutants, lacking the 
transmembrane domain - PRiMA and its different 
mutants were expressed in COS cells together with 
AChET subunits (also called T subunits). To 
evaluate the formation of heteromeric complexes, 
we analyzed the total AChE activity of the cellular 
extracts and of the medium, as well as their 
composition in molecular forms, using both 
sedimentation and non-denaturing electrophoresis. 
It should be noted that all molecular forms of 
AChE, which differ in their degree of 
oligomerization, with or without associated 
proteins, possess the same catalytic activity per 
active site, so that the level of AChE activity 
reflects the number of AChET subunits, 
independently of the composition in molecular 
forms.  
Fig. 2 illustrates the molecular forms 
obtained by expressing AChET subunits alone, with 
full-length PRiMA and with its extracellular 
fragment, Pstp54. As a control, we used an N-
terminal fragment of ColQ which contains the 
PRAD (residues 28-44), without the collagenous 
and trimerization domains (Qstp69) (Fig. 1C). When 
expressed alone or in the presence of a non 
interacting fragment of ColQ from which the 
proline-rich motif was deleted (∆[28-44]-Qstp69), T 
subunits produced mostly amphiphilic monomers 
(T1) and dimers (T2) (27), with a small proportion 
of nonamphiphilic tetramers sedimenting at 10.5 S, 
which are thought to be homomeric (T4), i.e. with 
no associated endogenous non catalytic component 
(Fig. 2A). Monomers and dimers are not readily 
resolved in the sedimentation profiles, and we 
therefore quantified their sum (T1+T2). The 
proportion of T4 tetramers is markedly higher in the 
medium than in the cell extract, indicating that they 
are secreted more efficiently than monomers and 
dimers, as previously observed (9).  
Co-expression of T subunits with full 
length PRiMA induced the formation of membrane-
bound T4-PRiMA complexes, expressed at the cell 
surface as demonstrated by immunofluorescence 
(not shown). These heteromeric complexes were 
recovered in the cell extract after solubilization in 
the presence of 1% Triton X-100; unlike 
homomeric tetramers (T4), which sediment at 10.5 
S regardless of the presence or absence of 
detergents, the PRiMA-associated tetramers are 
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amphiphilic and their sedimentation is influenced 
by detergents: they sediment at 9.8 S in the 
presence of Triton X-100 and 9 S in the presence of 
Brij-96. This was also shown by the fact that they 
migrated more slowly than T4 tetramers in non-
denaturing electrophoresis (Fig. 2B). In addition, 
the medium contained an increased level of soluble 
molecules sedimenting at 10.5 S, suggesting that 
they correspond to nonamphiphilic tetramers. When 
AChET subunits were co-expressed with an N-
flagged PRiMA, these secreted tetrameric 
molecules were recognized by an anti-flag antibody 
(M1), as shown by retardation of their migration in 
non denaturing electrophoresis (Fig. 3), 
demonstrating that they contain an N-terminal 
fragment of PRiMA, that might be produced either 
intracellularly or at the cell surface.  
Co-expression of AChET subunits with 
the Pstp54 mutant, corresponding to the extracellular 
domain of PRiMA, induced the formation of a 
soluble AChE form, sedimenting at 10.5 S, and 
migrating as an AChE tetramer in non-denaturing 
electrophoresis (Fig. 2A and B). This form, which 
could not be distinguished from homomeric T4 
tetramers by sedimentation, corresponds to AChET 
tetramers associated with the Pstp54 protein (T4-
Pstp54). The fact that the ratio of T4-Pstp54 to 
(T1+T2) is higher in the medium than in the cell 
extract, shows that they are preferentially secreted, 
as observed for homomeric tetramers T4.  
The formation of soluble T4-Pstp54 
complexes demonstrates that the amphiphilic 
character of T4-PRiMA complexes is due to the 
transmembrane domain of PRiMA and confirms 
that AChET subunits interact with a peptidic motif 
located in the N-terminal extracellular region of 
PRiMA, in agreement with a previous study (16). 
 
Effect of progressive C-terminal deletions in the 
extracellular domain of PRiMA on the recruitment 
of AChET subunits - We examined the interaction 
between AChET subunits and PRiMA mutants in 
which stop codons were introduced upstream of 
position 54 in mutants Pstp46, Pstp43, Pstp39, Pstp38, 
Pstp37, Pstp36, Pstp33 and Pstp31 (see Fig. 1B). We 
studied the AChE activity and molecular forms 
produced in COS cells expressing a constant 
amount of AChET subunits (2 µg of vector DNA 
per 60 mm culture dish), together with varying 
amounts of each mutant. 
The proportion of AChET tetramers 
increased in the cells and in the medium with the 
amount of associated non catalytic protein, as 
illustrated for Pstp33 and Pstp54 and Qstp69 in Fig. 4. 
This proportion was found to plateau at similar 
values for Pstp54 and Qstp69, but at a much lower 
level for Pstp33.  
Fig. 5 illustrates the effect of the Pstpn 
mutants on the cellular activity and on the rate of 
secretion, with a fixed amount of plasmid encoding 
the Pstpn mutants (2 µg of DNA encoding AChET 
and PRiMA mutant, each, per 60 mm culture dish). 
The level of cellular activity varied very little when 
AChET subunits were co-transfected with the 
various PRiMA mutants. Secretion increased by 
about 30% when AChET subunits were co-
transfected with Qstp69, indicating that they were 
partially rescued from intracellular degradation by 
the formation of T4-Qstp69 complexes (not shown), 
but reduced by about 50% when they were co-
transfected with Pstp31. The secreted activity 
gradually increased with the longer mutants Pstp33 
and Pstp36, approximately reaching the value 
obtained with AChET alone for longer constructs.  
The level of secreted (T1+T2) was 
markedly reduced, when AChET subunits were co-
transfected with any of the truncated Pstpn mutants, 
as well as with Qstp69, indicating that they 
interacted with all mutants, even the shorter ones, 
such as Pstp33 or Pstp31, which produced only 
minimal levels of cellular or secreted T4-Pstpn form. 
The variations observed in the level of secreted 
activity appeared correlated with the proportion of 
heteromeric complex in the medium, as shown in 
Fig. 5C. Remarkably, this correlation includes all 
the truncated PRiMA mutants analyzed in this 
study, and also Qstp69.  Fig. 5D shows that the 
secretion of T4-Pstpn complexes appears 
proportional to their cellular activity, except for T4-
Pstp36, which was more efficiently secreted, and for 
mutants containing A, D or E residues preceding 
the proline-rich segment, which are less efficiently 
secreted.  
The fact that AChE activity was reduced, 
both in the cells and in the medium, when AChET 
subunits were co-expressed with short truncated 
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PRiMA mutants such as Pstp31 suggests that they 
were more degraded than when expressed alone. 
This was verified by following the initial rate of 
recovery of AChE activity, during 2 hours after 
irreversible inhibition, i.e. before secretion of the 
newly synthesized enzyme: this rate represents the 
balance between neosynthesis and intracellular 
degradation. The rate of neosynthesis must be 
identical when AChET subunits are expressed with 
a non interacting protein and with different PRiMA 
mutants. We found that the rates of recovery varied 
in the order AChET + ∆[28-44]-Qstp69 > AChET + 
Pstp46 > AChET + Pstp33, indicating that Pstp33, and 
to a lesser degree Pstp46, induced some degradation 
of newly synthesized active AChET subunits.  
The ratio of secreted to the cellular 
activity of each molecular form of AChE can be 
considered as an index of its secretability: Fig. 6 
shows that this ratio remained essentially constant 
for (T1+T2), which were the same in all cases, but 
varied markedly for AChE tetramers associated 
with Pstpn proteins. This indicates that the secretion 
of the complexes depended on the length of the 
PRiMA fragment, especially between Pstp31 and 
Pstp36, confirming that complexes formed with the 
shorter PRiMA mutants were not efficiently 
secreted. In addition, the fact that this ratio varied 
in a non monotonic manner as a function of the 
length of the mutants from 36 to 54, suggests that 
the C-terminal residues of the Pstpn proteins may 
either facilitate or reduce secretion. 
The Pstp38 mutant seemed to produce a 
maximum of secreted heteromeric complexes, 
while Pstp36 appeared optimal for the secretability 
of such complexes. The differences observed 
between Pstp36, Pstp37, Pstp38 and Pstp39 show that 
the residues located immediately downstream of the 
prolines (RLL) influence the formation and the 
secretion of the T4-Pstpn complexes. However, 
replacement of R by an alanine or a glutamic acid 
in mutant Pstp37 (R36A-Pstp37 and R36E-Pstp37), or 
replacement of RLL by alanines in mutant 
(RLL/AAA-Pstp39) had essentially no effect on 
recruitment of AChET subunits, indicating that the 
charge of these residues is not important.  
It is interesting that Pstp46 and Pstp54 
produced very similar results, because Pstp54 
possesses a putative N-glycosylation site and a 
cysteine which are removed in Pstp46, suggesting 
that these two elements do not interfere, positively 
or negatively, with the interaction between PRiMA 
and AChET subunits in transfected COS cells. The 
lack of influence of these elements was confirmed 
by mutating cysteine C48 to a serine in Pstp54, and 
by suppressing the glycosylation site by replacing 
the threonine T46 by an alanine: these mutations 
did not affect the production and secretion of T4-
Pstpn complexes (not shown). 
 
Influence of the region preceding the poly-proline 
stretches - To assess the possible role of the 
peptidic region that precedes the poly-proline 
stretches of PRiMA, we deleted it in Pstp46 and 
Pstp54. To maintain a proper cleavage site between 
the signal peptide and the mature protein, the 
prolines stretches were preceded by an arginine R 
(as in the wild type), or by other charged or neutral 
residues (K, E, D, A), as shown in Fig. 1B.  
With an arginine preceding the prolines, 
we found that deletion of the N-terminal fragment 
(residues 1-19) from mutants Pstp46 or Pstp54 (∆N-
R-Pstp46 and ∆N-R-Pstp46) slightly reduced the 
amount of cellular and secreted complexes (Fig. 
5B). The fact that the two deleted mutants produced 
the same effect confirms that residues 45-53 do not 
influence the assembly or the trafficking of the 
complexes. 
We then examined a possible effect of a 
charged or neutral residue preceding the prolines, in 
mutants ∆N-R-Pstp46, ∆N-K-Pstp46, ∆N-A-Pstp46, 
∆N-D-Pstp46, and ∆N-E-Pstp46 (Fig. 5B and Fig. 6). 
We found that the amount of secreted AChE 
tetramers is higher with a neutral or acidic residue, 
but that their secretability appears lower, as 
indicated by the ratio of secreted to cellular 
activities, suggesting that this residue influences the 
efficiency of secretion (Fig. 5D).  
 It was surprising that the secretion of 
AChE complexes was lower with a positively 
charged residue upstream of the prolines, since this 
residue is an arginine (R) in the wild type PRiMA. 
However, when we replaced this arginine by a 
glutamic acid (E) in Pstp46, we found no 
modification of the yield of T4-Pstp46 complexes, 
indicating that this charge effect is negligible when 
the N-terminal segment (1-19) is present (not 
shown). 
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Mutations in the proline-rich region - PRiMA 
contains two groups of successive prolines, 
separated by a leucine residue (P4LP10). To 
determine whether this leucine is required for the 
interaction with AChET subunits, we mutated it to a 
proline, starting from the ∆N-E-Pstp46 mutant. The 
production and secretion of AChE tetramers 
remained unchanged with the resulting mutant, 
noted ∆N-(P15)-Pstp46. However, the production of 
complexes was significantly reduced by 
displacement of the leucine to a symmetrical 
position in the proline stretches (P10LP4) and even 
more by addition of a second leucine (P4LP5LP4), 
as shown in Fig. 5B. These mutations had little 
effect on the secretability of the complexes (Fig. 6). 
Thus, the recruitment of AChET subunits into 
heteromeric T4-Pstp46 complexes is weakened by an 
interruption of the proline stretches by a leucine, 
and this suggests that a succession of 10 prolines is 
sufficient to ensure a maximal efficiency. 
 
A proline-rich peptidic motif, sufficient for 
recruitment of AChET subunits - In the preceding 
sections, we showed that it is possible to maintain 
an efficient recruitment of AChET subunits into T4-
Pstpn hetero-oligomers after deletion of the N-
terminal region of PRiMA preceding R20 and of 
the C-terminal region following L37. Therefore, the 
20-37 peptidic motif, which contains the poly-
proline stretches (RP4LP10RL), may be sufficient 
for this interaction. To verify this conclusion, we 
combined N-terminal and C-terminal deletions in 
the ∆N-R-Pstp38 mutant. This mutant was co-
expressed with AChET subunits, and compared 
with Pstp54, ∆N-R-Pstp38 and Pstp38, all expressed at 
2 µg vector/dish (Fig. 5). All mutants induced the 
production of T4-Pstpn, confirming the effects 
observed with separate deletions of the N-terminal 
and C-terminal regions. Thus, the 18-residue 
peptide 20-37, derived from PRiMA, possesses the 
capacity to assemble four AChET subunits into 
stable T4-Pstpn complexes in a manner similar to 
that of the full length extracellular domain of 
PRiMA (Pstp54). 
It is noteworthy that deletion of the N-
terminal region, in ∆N-R-Pstp54 and ∆N-R-Pstp38 
increased the ratio of secreted to cellular T4-Pstpn 
by about 25%, compared to the corresponding 
mutants Pstp54 and Pstp38, suggesting that secretion 
was facilitated by the N-terminal deletion. Deletion 
of the C-terminal region, in Pstp38 and ∆N-R-Pstp38, 
compared to Pstp54 and ∆N-R-Pstp54, also appeared 
to increase its secretability.  
  
Assembly of AChET tetramers by synthetic peptides 
- We synthesized the PRiMA-derived peptides 
RP4LP10 and RP4LP10RL, to determine whether 
they could induce the assembly of AChET 
monomers and dimers into tetramers. In a first 
series of experiments, the peptides were added at a 
final concentration of 10-4 M to COS cells 
expressing only AChET subunits, during the 
transfection process and/or in the culture medium. 
The cells and the medium were analyzed by non 
denaturing electrophoresis after 3 days, as indicated 
above. This showed a clear increase in the 
proportion of AChET tetramers, most probably 
associated with the peptides (Fig. 7A). This result 
indicates that the peptides were able to penetrate 
the biosynthetic compartments of the living cells. 
In a second series of experiments, 
homogenates of COS cells expressing only AChET 
subunits were prepared without detergent, and 
incubated overnight at 37°C with the peptides (10-4 
M). As shown in Fig. 7B, both peptides induced the 
assembly of tetramers, under these acellular 
conditions. When a synthetic t peptide (WAT), at 
2.10-4 M, was added to the cell homogenate 
together with the PRiMA-derived peptides, it 
reduced markedly the recruitment of AChET 
monomers and dimers into tetramers, indicating a 
direct interaction between these peptides.  
 
DISCUSSION 
 
The N-terminal extracellular domain of PRiMA 
assembles AChET subunits into soluble T4-Pstpn 
complexes - The assembly of AChET tetramers with 
the transmembrane protein PRiMA produces 
membrane-bound complexes, both in the nervous 
system (14-18,31) and in muscles (19). In addition, 
the availability of PRiMA seems to limit the 
stabilization, as well as the functional localization 
of AChE in the mammalian brain (18). It is 
therefore important to analyze the interaction 
between PRiMA and AChET subunits. In this 
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study, we attempted to define the peptidic motif of 
PRiMA which is responsible for its quaternary 
association with AChET subunits, by using 
deletions upstream, downstream and within the 
proline-rich segment.  
We mostly used truncated PRiMA 
mutants, lacking the transmembrane and 
cytoplasmic domains (Pstpn with a stop codon at 
position n), which were co-expressed with AChET 
subunits in transiently transfected COS cells, 
producing soluble complexes (T4-Pstpn), which 
were secreted instead of remaining attached to the 
cell membrane.  
 
Truncated PRiMA mutants recruit AChET subunits 
into heteromeric complexes, following either 
secretion or degradation pathways - We have 
shown in a previous study that a significant fraction 
of AChET subunits is degraded intracellularly 
through the ERAD process, while another fraction 
is secreted (20,21). Therefore, the level of 
intracellular AChE activity reflects a balance 
between the rate of synthesis and the combined 
rates of degradation and secretion.  
When COS cells were transfected with a 
fixed amount of plasmid encoding AChET subunits, 
together with various amounts of plasmid encoding 
PRiMA mutants, a variable fraction of the subunits 
was integrated in T4-Pstpn complexes, both in the 
cells and in the medium. It was surprising to find 
that, although the proportion of T4-Pstpn complexes 
varied widely, it appeared to plateau for similar 
amounts of plasmid DNA, suggesting that all 
mutants presented a similar apparent “affinity” for 
AChET subunits. This paradox can be resolved by 
assuming that even when the observed proportion 
of complexes was very low, mutants such as Pstp31 
did in fact interact with AChET subunits, as 
indicated by a marked reduction in the secretion of 
(T1+T2), but produced rapidly degraded complexes. 
With longer mutants, the level of secreted T4-Pstpn 
complex progressively increased. Thus, the 
variations observed in the amount of secreted 
complex appear to reflect a competition between 
secretion and degradation. Depending on its 
organization, each type of T4-Pstpn complex would 
be oriented with different probabilities towards the 
secretion pathway or the degradation pathway. This 
suggests that the rate of secretion depends critically 
on the structure of the complex. 
It is a classical notion that proteins 
destined to function as a multi-subunit complex 
may be retained in the endoplasmic reticulum by 
the quality control system of the cell, unless they 
are appropriately associated with their partners 
(32). This can be rationalized by the fact that they 
expose hydrophobic surfaces in their unassembled 
state, but not in the complex. This seems to be the 
case for Torpedo AChET subunits, which are very 
little secreted when expressed alone in COS cells, 
but can be secreted when co-expressed with an N-
terminal fragment of ColQ (Qstp69) (5). We also 
observed here that rat AChET subunits can be 
rescued by Qstp69 from degradation through ERAD 
(20). This is consistent with the fact that their 
physiological function depends on association with 
an anchoring protein, ColQ or PRiMA. 
The fact that short truncated PRiMA 
mutants increase the intracellular degradation of 
AChET subunits is more unusual. However, Ulloa-
Aguirre and Conn recently suggested that some 
proteins induce an inappropriate conformation of 
normally externalized molecules and thus target 
them towards degradation by the cellular quality 
control, and proposed to call this hypothetical 
process “protein shipwrecking” (33). Here, we 
present evidence that some PRiMA mutants may 
behave in this manner, and that there is in fact a 
continuous spectrum between mutants which 
induce degradation and those which rescue AChET 
subunits from ERAD and promote their secretion as 
heteromeric complexes.  
Since the assembly of a complex between 
proteins occludes interaction surfaces, rather than 
exposing hydrophobic zones, how could the 
association with short PRiMA mutants such as 
Pstp31 induce the degradation of AChET subunits? 
Although we have presently no experimental 
evidence, we may propose an hypothetical 
explanation. We have previously demonstrated that 
aromatic (but not hydrophobic) residues of the C-
terminal t peptide of AChE play a crucial role to 
induce the degradation of AChET subunits by 
ERAD (22). It is possible that a group of aromatic 
residues remains exposed in the complexes formed 
with short PRiMA mutants, engaging their 
translocation into the cytoplasm and degradation by 
proteasomes, whereas these residues are masked in 
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complexes formed with longer mutants, as 
demonstrated by crystallography in a complex of 
four t peptides with the PRAD of ColQ (12). 
 
Definition of a sufficient interaction motif (PRAD) 
in PRiMA - The efficiency of secretion of AChE 
oligomers increases with their degree of 
oligomerization (9). The secretability of 
heteromeric T4-Pstpn complexes, indicated by the 
ratio of secreted to cellular activity, was variable: it 
is noteworthy that it was increased by deletion of 
peptidic regions located upstream or downstream of 
the poly-proline stretches. A maximum was 
obtained by removing all residues following the 
prolines (Pstp36); conversely, it was reduced for 
mutants in which the N-terminal region was deleted 
(ΔN) and the proline-rich segment was preceded by 
residues A, E, or D, as opposed to basic residues R 
or K.  
Most of the N-terminal and C-terminal 
regions flanking the poly-proline stretches could be 
deleted without suppressing the capacity of P 
mutants to engage AChET subunits into T4-Pstpn 
complexes. This capacity in fact appeared maximal 
when most of the C-terminal region was deleted, 
leaving only two residues (RL) after the prolines, in 
Pstp73. However, it is not certain that these residues 
play a specific role in the association with t 
peptides, because replacement of the three residues 
following the prolines by alanines had essentially 
no effect (in RLL/AAA-Pstp39 versus Pstp39). Even 
though we have no direct evidence that Pstp54 is N-
glycosylated under our experimental conditions, we 
found that the presence of a putative N-
glycosylation site, located at position 44, did not 
influence the association of PRiMA mutants with 
AChET subunits. Similarly, the cysteine located at 
position 48 did not affect the formation of T4-Pstpn 
complexes.  
The PRAD of ColQ is normally disulfide-
linked to two of the t peptides, while the other two 
are disulfide-linked together (5), and it has been 
reported that, as in the case of ColQ, two of the 
AChET subunits are disulfide-linked with the 
membrane anchor, in brain AChE (14,15). 
However, we previously found that the formation 
of heteromeric complexes with the N-terminal 
region of ColQ could occur without the two 
adjacent cysteines preceding the PRAD, indicating 
that disulfide bonds between ColQ and two AChET 
subunits are not required (5,11). The present results 
suggest a similar conclusion, since the formation of 
complexes was only slightly reduced (20% or less) 
by deletion of most of the N-terminal region, which 
contains four cysteines, located at positions 6, 13, 
17, 19. This does not rule out the possibility that 
some of these cysteines may be involved in 
intercatenary disulfide bonds between PRiMA and 
AChET subunits, as shown in membrane-anchored 
AChE tetramers from bovine brain (14,15,34), and 
thus stabilize the complex.  
PRiMA contains two poly-proline 
stretches, separated by a leucine (P4LP10). We 
found that this leucine is not required for the 
interaction, and could be replaced by a proline, 
resulting in a single suite of 15 prolines (P15). The 
secretion of T4-Pstpn complexes was decreased by 
displacement of the leucine (P10LP4) or 
interruption of the proline stretches by a second 
leucine (P4LP5LP4) and it was almost totally 
abolished when 5 prolines were deleted in Pstp31 
(P4LP5). Thus, the formation of secretable 
complexes requires the presence of a minimal 
number of uninterrupted prolines.  
Our deletion experiments converged on 
the idea that the 20-37 segment of PRiMA 
(RP4LP10RL) may be able to recruit AChET 
subunits nearly as efficiently as the entire 
extracellular domain of PRiMA, and this was 
confirmed by expressing this 18-residue peptide, as 
mutant ∆N-R-Pstp38. In fact, addition of the 
synthetic peptides RP4LP10 and RP4LP10RL to 
COS cells expressing only AChET subunits induced 
the recruitment of monomers and dimers into stable 
tetramers. Moreover, we obtained the same result 
by incubating a cell homogenate with the peptides, 
and observed that the assembly of AChET tetramers 
was partially blocked by addition of a synthetic t 
peptide (WAT). This proves that the PRiMA-
derived and t peptides spontaneously interact in 
vitro, as shown previously for a ColQ-derived 
PRAD peptide (12), and opens the way to the 
formation, crystallization and structural analysis of 
the core complex which forms the basis of the 
association between PRiMA and AChET. It is 
noteworthy that the PRAD of ColQ is very efficient 
with only 8 prolines (P3MFP5). This raises the 
intriguing possibility that the complexes of t 
peptides with the proline-rich motifs of ColQ and 
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PRiMA might significantly differ in their 
quaternary organization. Using short PRiMA-
derived peptides, it may also be possible to shed 
some light on the structural differences between 
complexes that pass or fail the quality control in the 
secretory pathway. 
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1The abbreviations used are: AChE: acetylcholinesterase (E.C. 3.1.1.7); AChET: splice variant T; 
PRiMA: Proline-Rich Membrane Anchor; ColQ: collagen Q; ERAD: Endoplasmic Reticulum 
Associated degradation; PRAD: Proline-Rich Attachment Domain; Pstpn: truncated PRiMA mutant, 
terminating with a stop codon at position n; ∆N-X-Pstpn: PRiMA mutant, with a deletion of the N-
terminal fragment, starting with residue X before the prolines, and terminating with a stop codon at 
position n; WAT: Tryptophan (W) Amphiphilic Tetramerization domain. 
 
 
FIGURE LEGENDS 
 
Fig. 1. Structure of PRiMA and of mutants used in this study. A. Sequence of PRiMA, numbered 
from the first residue of the mature protein. The putative signal peptide is shown in thin letters (-35 
to –1), the extracellular domain in bold letters (1 to 53), the transmembrane domain in bold italics, 
and the cytoplasmic domain in thin italics (the sequence shown corresponds to the major splice 
variant PRiMA I, possessing the longer cytoplasmic domain). In the extracellular domain, the 
putative N-glycosylation site is indicated by an asterisk and the cysteines are underlined. B. 
Structure of mutants. All mutants possess the signal peptide (not shown), and fragments of the 
extracellular domain, but not the transmembrane and cytoplasmic domains. They are designated by 
the position of introduced stop codons (e.g. Pstp54 contains the entire extracellular domain, 1-53). 
The deletion of the region preceding the poly-proline stretches is indicated by D; in these mutants, a 
single residue precedes the prolines, so as to maintain a proper cleavage site after the signal peptide: 
this residue is indicated, e.g. arginine (R) in ∆N-R-Pstp54.  Mutants in the proline-rich region are 
indicated by the distribution of prolines and leucine residues (e.g. P4LP10 in the case of the wild 
type). The interaction motif (RP4LP10RL) corresponds to mutant ∆N-R-Pstp38. C. Structure of the 
N-terminal fragment of Torpedo ColQ (Qstp69) (the signal peptide is not shown). The underlined 
fragment corresponds to the PRAD interaction domain. It was deleted in ∆[28-44]Qstp69. 
  
 
Fig. 2. Molecular forms of AChE produced and secreted by transient transfection of COS cells with 
AChET expressed alone, with full length PRiMA and with truncated PRiMA, reduced to its 
extracellular domain (Pstp54). A. Representative sedimentation profiles, obtained from gradients 
containing 1% Brij-96, normalized to the same total AChE activity, indicating the relative 
proportions of monomers (T1), dimers (T2) and tetramers, associated or not with PRiMA or Pstp54. 
Profiles corresponding to cell extracts are shown in the top panel, and to the medium in the middle 
panel. (o): AChET expressed alone; (■):AChET expressed with PRiMA; (- -▲- -): 
AChET expressed with Pstp54.  In general, the relative proportion in the medium, compared to cell 
extracts, increases with the degree of oligomerization, indicating that secretion is facilitated by 
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oligomerization. Soluble non amphiphilic tetramers (T4) and heteromeric  complexes (T4-Pstp54) 
sediment around 10.5 S, while amphiphilic T4-PRiMA complexes, containing the transmembrane 
domain of PRiMA, are retarded by their interaction with the detergent (Brij-96) and sediment 
around 9 S. B. Migration of AChE forms from cell extracts and culture media in non denaturing 
electrophoresis. In the profiles corresponding  to co-transfected cells (AChET with PRiMA and 
AChET with the extracellular domain of PRiMA, Pstp54), the simple arrows indicate non 
amphiphilic AChE tetrameric forms; the arrow with an asterisk indicates the amphiphilic tetramer 
associated with a complete PRiMA protein. 
 
Fig. 3. Secreted AChE tetramers induced by co-transfection of AChET subunits with PRiMA 
contain an N-terminal fragment of PRiMA. The electrophoretic migration of AChE tetramers 
secreted by COS cells expressing AChET subunits with an N-flag-PRiMA was retarded, in non-
denaturing gels, after incubation with the monoclonal anti-flag antibody M1. AChE tetramers are 
indicated by arrows and the retarded component by an asterisk. 
 
Fig. 4. Variation of the proportion of AChE tetramers with the amount of PRiMA mutants. COS 
cells were transfected with a fixed amount of DNA encoding AChET subunits (2 µg per 60 mm 
culture dish) and the indicated amount of DNA encoding PRiMA mutants, or the N-terminal region 
of ColQ (Qstp69), complemented with DNA encoding a non interacting protein, so that the total 
amount of vector was kept constant to avoid modifications in the protein synthesis capacity of the 
cells. The proportions tetramers, associated or not with Pstpn proteins (T4 + T4-Pstpn) was 
determined from sedimentation profiles, as in Fig. 2. The figure illustrates the results obtained for 
Pstp31 and Pstp54 mutants, producing respectively high or low proportions of T4-Pstpn complexes. 
The curves obtained with all other mutants were very similar in shape, differing mostly by the 
maximal levels of tetramers: co-transfection with 2 µg DNA/dish encoding the various mutants was 
used in most subsequent experiments.  
 
Fig. 5. Effect of the PRiMA mutants on cellular and secreted AChE activity and molecular forms. 
COS cells were co-transfected with 2 µg of DNA encoding AChET and 2 µg of DNA encoding 
PRiMA mutants. A. Sequence and numbering of the extracellular domain of PRiMA; the cysteines 
are underlined and the putative N-glycosylation site is indicated by an asterisk. B. The cellular and 
secreted AChE activities corresponding to the different mutants were normalized, for each 
experiment, to those of AChET subunits expressed alone, taken as 100%.  The proportions of the 
molecular forms were determined from sedimentation profiles. The data corresponding to C-
terminal truncated mutants (1 to 9) are the means of 4 to 7 independent transfection experiments, + 
standard errors; those for other mutants correspond to a representative experiment. The lightly 
hatched boxes correspond to the activity of monomers and dimers (T1+T2) and the darkly hatched 
boxes to tetramers (homomeric tetramers T4 and heteromeric T4-Pstpn complexes). If homomeric T4 
tetramers are present in the same proportion to T1 and T2, as in the case of AChET subunits alone, 
they represent a minor species and can be generally neglected. In mutants 16 to 18, the deletion of 
the N-terminal region is associated with mutations in the proline-rich segment, as indicated in 
parentheses. Note that a mutant reduced to the RP4LP10RL motif (expressed as mutant ∆N-R-Pstp38) 
induced the production and secretion of essentially the same amount of complex as the complete 
extracellular domain (Pstp54 mutant). C. Correlation between the total secreted AChE activity and 
the proportion of tetramers in the medium. The numbers identify the mutants, as indicated in the left 
column of A. D. Correlation between the percentages of T4 complexes in secreted and cellular 
AChE. 
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Fig. 6. Ratio of secreted to cellular activity of AChE forms. The secreted activity reflects the rate of 
secretion, whereas the cellular activity, 3-4 days after transfection, approximately corresponds a 
steady state value; therefore, these activities are not comparable, but their ratio may be considered 
as an index of the efficiency of secretion, for each AChE form. These ratios were arbitrarily 
normalized to 100 for AChE tetramers produced in co-transfection with the complete N-terminal 
domain of PRiMA, Pstp54. For monomers and dimers (T1+T2), the ratio remained approximately 
constant, in agreement with the fact that their structure did not change. 
 
Fig. 7. Synthetic PRiMA peptides induce oligomerization of AChET subunits in vitro. A. COS cells 
were transfected with AChET and the synthetic peptides RP4LP10 and RP4LP10RL were added with 
fresh culture medium after 2 days. The cells were extracted 24 hours later and analysed by non 
denaturing electrophoresis, as well as the medium. B. The peptides were added at a concentration of 
10-4 M to an homogenate of COS cells expressing only AChET subunits, and incubated overnight at 
37°C. In some samples, a synthetic t peptide (WAT) was added at 2 10-4 M, as indicated. The 
homogenate was then analyzed by non denaturing electrophoresis in the presence of detergents (see 
Methods). The peptides induced the formation of stable AChET tetramers (indicated by arrows); 
this effect was reduced by addition of the t peptide (WAT).  
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B Sequences of truncated PRiMA mutants
C-terminal truncations (Pstpn)
Pstp46   EPQKSCSKVTDSCQHICQCRPPPPLPPPPPPPPPPRLLSAPAPNS
EPQKSCSKVTDSCQHICQCRPPPPLPPPPPPstp31   
Mutations of leucines in the poly-proline stretches
E-------------------PPPPPPPPPPPPPPPRLLSAPAPNSP15
E-------------------PPPPLPPPPPLPPPPRLLSAPAPNSP4LP5LP4
E-------------------PPPPPPPPPPLPPPPRLLSAPAPNSP10LP4  
N-terminal deletions 
RPPPPLPPPPPPPPPPRLLSAPAPNS∆Ν-R-Pstp46   
E-------------------PPPPLPPPPPPPPPPRLLSAPAPNS
1
∆Ν-E-Pstp46   
Interaction motif 
RPPPPLPPPPPPPPPPRL∆Ν-R-Pstp38   
EPQKSCSKVTDSCQHICQCRPPPPLPPPPPPPPPPRLLSAPAPNSTSCPAEDSPstp54   
C Sequence of the ColQ-derived N-terminal fragment
Qstp69 ESTFLDKAFSLQAALLPMEHKKRSVNKCCLLTPPPPPMFPPPFFTETNIL
55 60 65
QEVDLNNLPLEIKPTEPS
A Sequence of mouse PRiMA
N-term.
domain EPQKSCSKVTDSCQHICQCRPPPPLPPPPPPPPPPRLLSAPAPNSTSCPAEDS
15105 20 25 30 4035 45 501 *
Signal 
peptide MLLRDLVPRHGCCWPSLLLHCALHPLWGLVQVTHA
-1-5-1
0
-1
5
-2
0
-2
5
-3
0
-3
5
TM 
domain WWSGLVIIVAVVCASLVFLTVLVII
55 60 65 70 75
C-ter. I
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